Responses
Clinical/translational cancer immunotherapy
Original research
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity
Compose a Response to This Article
Other responses
No responses have been published for this article.